My Quote Request
No products added yet
6505-01-523-0353
20 Products
ZOMIG ZMT
ZOLMITRIPTAN TABLET
NSN, MFG P/N
6505015230353
NSN
6505-01-523-0353
MFG
ASTRAZENECA LP
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 28:92.00
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ZOLMITRIPTAN TABLETS BLISTER PACK 6S
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH: ZOLMITRIPTAN 2.5 MG; ORALLY RAPIDLY DISINTEGRATING TABLETS; INDIVIDUALLY SEALED; USED IN TREATMENT OF MIGRAINES; PKG. OF 6
Related Searches:
NDC00310-0209-20
ZOLMITRIPTAN TABLET
NSN, MFG P/N
6505015230353
NSN
6505-01-523-0353
MFG
VETERANS HEALTH
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 28:92.00
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ZOLMITRIPTAN TABLETS BLISTER PACK 6S
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH: ZOLMITRIPTAN 2.5 MG; ORALLY RAPIDLY DISINTEGRATING TABLETS; INDIVIDUALLY SEALED; USED IN TREATMENT OF MIGRAINES; PKG. OF 6
Related Searches:
04-0941
OSELTAMIVIR PHOSPHA
NSN, MFG P/N
6505015230821
NSN
6505-01-523-0821
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OSELTAMIVIR PHOSPHATE ORAL SUSPENSION 12MG/ML 300 MG BT
SPECIAL FEATURES: WHITE POWDER BLEND, 25 ML AFTER RECONSTITUTION, FLAVORED, BOTTLE ADAPTER W/ORAL DISPENSER (GRADUATION OF 30, 45 AND 60 MG); STORE DRY POWDER AT 25 DEG C; STORE CONSTITUTED SUSPENSION UNDER REFRIGERATION BETWEEN 2-8 DEG C; DO NOT FREEZE; FOR PATIENTS 1
~1: YEAR AND OLDER; AHFS:081800
Related Searches:
NDC00004-0810-95
OSELTAMIVIR PHOSPHA
NSN, MFG P/N
6505015230821
NSN
6505-01-523-0821
MFG
ROCHE LABORATORIES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OSELTAMIVIR PHOSPHATE ORAL SUSPENSION 12MG/ML 300 MG BT
SPECIAL FEATURES: WHITE POWDER BLEND, 25 ML AFTER RECONSTITUTION, FLAVORED, BOTTLE ADAPTER W/ORAL DISPENSER (GRADUATION OF 30, 45 AND 60 MG); STORE DRY POWDER AT 25 DEG C; STORE CONSTITUTED SUSPENSION UNDER REFRIGERATION BETWEEN 2-8 DEG C; DO NOT FREEZE; FOR PATIENTS 1
~1: YEAR AND OLDER; AHFS:081800
Related Searches:
TAMIFLU
OSELTAMIVIR PHOSPHA
NSN, MFG P/N
6505015230821
NSN
6505-01-523-0821
MFG
ROCHE LABORATORIES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OSELTAMIVIR PHOSPHATE ORAL SUSPENSION 12MG/ML 300 MG BT
SPECIAL FEATURES: WHITE POWDER BLEND, 25 ML AFTER RECONSTITUTION, FLAVORED, BOTTLE ADAPTER W/ORAL DISPENSER (GRADUATION OF 30, 45 AND 60 MG); STORE DRY POWDER AT 25 DEG C; STORE CONSTITUTED SUSPENSION UNDER REFRIGERATION BETWEEN 2-8 DEG C; DO NOT FREEZE; FOR PATIENTS 1
~1: YEAR AND OLDER; AHFS:081800
Related Searches:
04-1172
VALPROATE SODIUM IN
NSN, MFG P/N
6505015231356
NSN
6505-01-523-1356
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VALPROATE SODIUM INJECTION (10) VIALS PER PACKAGE
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH 100 MG PER ML, 5 ML SINGLE DOSE VIALS, PACKAGE OF 10; PRESERVATIVE FREE; ADMINISTRATION: INTRAVENOUSLY; VALPROATE IS INDICATED FOR TREATMENT OF PATIENTS WITH COMPLEX PARTIAL SEIZURES THAT OCCURS EITHER IN ISOLATION OR IN
~1: ASSOCIATION WITH OTHER TYPES OF SEIZURES; STORE VIALS AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
Related Searches:
NDC55390-0007-10
VALPROATE SODIUM IN
NSN, MFG P/N
6505015231356
NSN
6505-01-523-1356
MFG
BEN VENUE LABORATORIES INC DBA BEDFORD LABORATORIES
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VALPROATE SODIUM INJECTION (10) VIALS PER PACKAGE
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH 100 MG PER ML, 5 ML SINGLE DOSE VIALS, PACKAGE OF 10; PRESERVATIVE FREE; ADMINISTRATION: INTRAVENOUSLY; VALPROATE IS INDICATED FOR TREATMENT OF PATIENTS WITH COMPLEX PARTIAL SEIZURES THAT OCCURS EITHER IN ISOLATION OR IN
~1: ASSOCIATION WITH OTHER TYPES OF SEIZURES; STORE VIALS AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
Related Searches:
04-1221
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505015231382
NSN
6505-01-523-1382
04-1221
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505015231382
NSN
6505-01-523-1382
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS MIDAZOLAM EQUIVALENT PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282408
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 1MG/ML 1ML VIALS 25S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: FOR USE TO PROVIDE SEDATION BEFORE SURGERY OR DURING DIAGNOSTIC PROCEDURES; STORE PRODUCT AT ROOM TEMPERATURE (15-30 DEG. C)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
1001902703
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505015231382
NSN
6505-01-523-1382
1001902703
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505015231382
NSN
6505-01-523-1382
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS MIDAZOLAM EQUIVALENT PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282408
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 1MG/ML 1ML VIALS 25S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: FOR USE TO PROVIDE SEDATION BEFORE SURGERY OR DURING DIAGNOSTIC PROCEDURES; STORE PRODUCT AT ROOM TEMPERATURE (15-30 DEG. C)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC10019-0027-03
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505015231382
NSN
6505-01-523-1382
NDC10019-0027-03
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505015231382
NSN
6505-01-523-1382
MFG
BAXTER HEALTHCARE CORPORATION DIV MEDICATION DELIVERY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS MIDAZOLAM EQUIVALENT PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282408
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 1MG/ML 1ML VIALS 25S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: FOR USE TO PROVIDE SEDATION BEFORE SURGERY OR DURING DIAGNOSTIC PROCEDURES; STORE PRODUCT AT ROOM TEMPERATURE (15-30 DEG. C)
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC66213-0425-10
BELLADONNA ALKALOIDS AND PHENOBARBITAL TABLETS
NSN, MFG P/N
6505015231419
NSN
6505-01-523-1419
NDC66213-0425-10
BELLADONNA ALKALOIDS AND PHENOBARBITAL TABLETS
NSN, MFG P/N
6505015231419
NSN
6505-01-523-1419
MFG
PBM PRODUCTS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 16.200 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 120808
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BELLADONNA ALKALOIDS AND PHENOBARBITAL TABLETS (100) TABLETS PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: INGREDIENTS AND STRENGTH BELLADONNA ALKALOIDS AND PHENOBARBITAL 16.2 MG; USED TO TREAT IRRITABLE BOWEL SYNDROME, INFLAMMATION OF THE INTESTINE, AND ULCERS IN THE INTESTINE; STORE AT ROOM TEMPERATURE AND AWAY FROM EXCESS HEAT AND MOISTURE
Related Searches:
04-1170
ZOLMITRIPTAN TABLET
NSN, MFG P/N
6505015232352
NSN
6505-01-523-2352
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 28:29.00
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ZOLMITRIPTAN TABLETS 2.5MG 6 PER BLISTER PACK
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH: 2.5 MG ZOLMITRIPTAN; USED IN TREATMENT OF MIGRAINES; STORE AT ROOM TEMPERATRUE; BLISTER PKG OF 6 TABLETS
Related Searches:
NDC00037-7310-20
ZOLMITRIPTAN TABLET
NSN, MFG P/N
6505015232352
NSN
6505-01-523-2352
MFG
MEDA PHARMACEUTICALS INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 28:29.00
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ZOLMITRIPTAN TABLETS 2.5MG 6 PER BLISTER PACK
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH: 2.5 MG ZOLMITRIPTAN; USED IN TREATMENT OF MIGRAINES; STORE AT ROOM TEMPERATRUE; BLISTER PKG OF 6 TABLETS
Related Searches:
ZOMIG
ZOLMITRIPTAN TABLET
NSN, MFG P/N
6505015232352
NSN
6505-01-523-2352
MFG
MEDA PHARMACEUTICALS INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 28:29.00
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ZOLMITRIPTAN TABLETS 2.5MG 6 PER BLISTER PACK
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH: 2.5 MG ZOLMITRIPTAN; USED IN TREATMENT OF MIGRAINES; STORE AT ROOM TEMPERATRUE; BLISTER PKG OF 6 TABLETS
Related Searches:
04-1186
KETOROLAC TROMETHAMINE INJECTION,USP
NSN, MFG P/N
6505015232367
NSN
6505-01-523-2367
04-1186
KETOROLAC TROMETHAMINE INJECTION,USP
NSN, MFG P/N
6505015232367
NSN
6505-01-523-2367
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS KETOROLAC TROMETHAMINE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280804
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE INJECTION 30 MG PER ML (10) PER PACKAGE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: 2ML CARPUJECT LUER LOCK; THIS MEDICINE IS A NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) USED FOR SHORT TERM PAIN RELIEF; STORE IN A TIGHT, LIGHT RESISTANT CONTAINER AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00074-2287-61
KETOROLAC TROMETHAMINE INJECTION,USP
NSN, MFG P/N
6505015232367
NSN
6505-01-523-2367
NDC00074-2287-61
KETOROLAC TROMETHAMINE INJECTION,USP
NSN, MFG P/N
6505015232367
NSN
6505-01-523-2367
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS KETOROLAC TROMETHAMINE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280804
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE INJECTION 30 MG PER ML (10) PER PACKAGE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: 2ML CARPUJECT LUER LOCK; THIS MEDICINE IS A NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) USED FOR SHORT TERM PAIN RELIEF; STORE IN A TIGHT, LIGHT RESISTANT CONTAINER AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
04-1188
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505015232380
NSN
6505-01-523-2380
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HALOPERIODAL TABLETS 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED TO TREAT NERVOUS, MENTAL AND EMOTIONAL CONDITIONS SUCH AS HALLUCINATIONS, DELUSIONS AND HOSTILITY AND TO CONTROL MUSCULAR TICS OF THE FACE, NECK, HANDS, AND SHOULDERS; KEEP TIGHTLY CLOSED; STORE AT ROOM TEMPERATURE AND AWAY FROM EXCESS HEAT AND
~1: MOISTURE
Related Searches:
NDC00378-0327-01
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505015232380
NSN
6505-01-523-2380
NDC00378-0327-01
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505015232380
NSN
6505-01-523-2380
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HALOPERIODAL TABLETS 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED TO TREAT NERVOUS, MENTAL AND EMOTIONAL CONDITIONS SUCH AS HALLUCINATIONS, DELUSIONS AND HOSTILITY AND TO CONTROL MUSCULAR TICS OF THE FACE, NECK, HANDS, AND SHOULDERS; KEEP TIGHTLY CLOSED; STORE AT ROOM TEMPERATURE AND AWAY FROM EXCESS HEAT AND
~1: MOISTURE
Related Searches:
NDC00781-1396-01
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505015232380
NSN
6505-01-523-2380
NDC00781-1396-01
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505015232380
NSN
6505-01-523-2380
MFG
SANDOZ CONSUMER HEALTH CARE GROUP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281608
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HALOPERIODAL TABLETS 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: USED TO TREAT NERVOUS, MENTAL AND EMOTIONAL CONDITIONS SUCH AS HALLUCINATIONS, DELUSIONS AND HOSTILITY AND TO CONTROL MUSCULAR TICS OF THE FACE, NECK, HANDS, AND SHOULDERS; KEEP TIGHTLY CLOSED; STORE AT ROOM TEMPERATURE AND AWAY FROM EXCESS HEAT AND
~1: MOISTURE
Related Searches:
04-1129
RIFAXIMIN TABLETS
NSN, MFG P/N
6505015232382
NSN
6505-01-523-2382
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081228
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RIFAXIMIN TABLETS 200MG (30) TABLETS PER BOTTLE
SPECIAL FEATURES: ACTIVE INGREDIENT AND STRENGTH: 200MG RIFAXIMIN; 30 TABLETS PER BOTTLE; ADMINISTERED ORALLY WITH OR WITHOUT FOOD; STORE AT 20 TO 25 DEGREES C (68 TO 77 DEGREES) CONTROLLED ROOM TEMPERATURE
